What measures reduce the rate of central line-associated bloodstream infections (CLABSI)?

Reducing Central Line-Associated Bloodstream Infections (CLABSI)

Implement a comprehensive bundle approach that includes maximal sterile barrier precautions during insertion, >0.5% chlorhexidine-based skin antisepsis, daily chlorhexidine bathing, proper dressing management with chlorhexidine-impregnated sponges for high-risk patients, and disinfection of catheter hubs before each access—this combination has demonstrated CLABSI rate reductions from 15.34 to 2.23 per 1,000 catheter-days. 1

Essential Prevention Measures During Insertion

Maximal Sterile Barrier Precautions

• Use full-body drapes, sterile gown, sterile gloves, mask, and cap for all central line insertions 2
• This is non-negotiable and forms the foundation of CLABSI prevention

Skin Antisepsis

• Use >0.5% chlorhexidine gluconate in alcohol for skin preparation 2, 1
• Allow the antiseptic to dry completely per manufacturer recommendations before catheter insertion 2
• For infants <2 months, safety data for chlorhexidine remains uncertain 2

Site Selection

• Avoid femoral and internal jugular sites when possible—these carry higher infection risk 1
• Peripherally inserted central catheters (PICCs) have the lowest infection risk 1
• Choose subclavian site over internal jugular or femoral when feasible

Critical Maintenance Interventions

Daily Chlorhexidine Bathing

• Perform daily skin cleansing with 2% chlorhexidine wash to reduce catheter-related bloodstream infections 2
• This simple intervention significantly impacts infection rates

Dressing Management

• Replace transparent dressings at least every 7 days for short-term central venous catheters 2, 1
• Change gauze dressings every 2 days 2, 1
• Replace immediately if dressing becomes soiled, loose, or damp 2, 1
• Use chlorhexidine-impregnated sponge dressings for temporary short-term catheters in patients >2 months if CLABSI rates remain elevated despite basic measures 2

Hub and Port Disinfection

• Disinfect catheter hubs, needleless connectors, and injection ports before each access 1
• Use antiseptic-containing caps (70% isopropyl alcohol, iodinated alcohol, or chlorhexidine) for passive disinfection of needleless connectors 1
• This addresses intraluminal contamination, a major source of infection

Equipment Considerations

• Use sutureless securement devices to reduce infection risk 2
• Implement needleless connectors instead of three-way stopcocks 1
• Use positive displacement needleless connectors over negative or neutral displacement 1
• Consider collapsible closed-system IV fluid containers over open systems 1

Advanced Interventions for Persistently High Rates

Antimicrobial-Impregnated Catheters

• Use chlorhexidine/silver sulfadiazine or minocycline/rifampin-impregnated catheters if the catheter will remain >5 days AND CLABSI rates remain elevated despite comprehensive prevention strategies 2
• Only implement after ensuring education, maximal sterile barriers, and chlorhexidine skin antisepsis are already in place 2

What NOT to Do

Avoid These Interventions

• Do not use systemic antimicrobial prophylaxis before insertion or while catheters are in place 2, 1
• Do not routinely replace central lines or arterial catheters 1
• Do not use topical antibiotic ointments on insertion sites (except dialysis catheters) due to fungal infection risk and antimicrobial resistance 2

Implementation Strategy

Bundle Approach

The most effective strategy combines multiple interventions simultaneously rather than implementing measures individually. Real-world implementation across 30 countries demonstrated CLABSI reduction from 15.34 to 2.23 per 1,000 catheter-days using bundled interventions 1. A pediatric study showed reduction from 10.5 to 3.6 per 1,000 catheter-days 1.

Education and Accountability

• Train all personnel who insert and maintain catheters 2
• Monitor compliance with insertion checklists—one study increased compliance from 22.8% to 56.9% with corresponding CLABSI reduction 3
• Establish governance structures with clear accountability 3

Monitoring

• Track CLABSI rates per 1,000 catheter-days as the primary outcome measure
• Monitor bundle compliance rates (target >90%) 4, 5
• Assess catheter utilization ratios to ensure reductions reflect improved care, not decreased device use 4

Clinical Context

CLABSI significantly increases mortality (from 14.06% to 39.81%), prolongs hospital stay (from 6.57 to 23.17 days), and substantially increases healthcare costs 1. These infections are independent mortality risk factors even after controlling for other variables 1.

Common Pitfalls

• Implementing single interventions rather than comprehensive bundles—this rarely achieves sustained reduction
• Failing to address both insertion AND maintenance practices—both are equally critical
• Not allowing antiseptics to dry completely before catheter insertion
• Using femoral sites when alternatives exist
• Neglecting hub disinfection before each access
• Assuming education alone will change practice without monitoring compliance

The evidence strongly supports that nurse-led implementation with structured protocols and compliance monitoring achieves superior outcomes 4. One nurse-led initiative achieved 63.2% CLABSI reduction with compliance increasing from 78% to 94.4% 4.